Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-13

Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

View source ↗

Summary

This multicenter retrospective study evaluates the incidence of breast cancer in adult female Hodgkin lymphoma survivors treated with MBVD (including non-pegyla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bleomycin (bleomycin)
  • Dacarbazine (dacarbazine)
  • Vinblastine (vinblastine)
  • liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Federico II University | Conditions: Hodgkin Disease, Breast Cancer | Status: COMPLETED